ALK and anaplastic large cell lymphoma: This case illustrates the feasibility of CD30/CD7 CAR-T therapy in CNS ALK-negative ALCL and supports further investigation into antigen-specific CAR-T approaches for rare T-cell malignancies of the CNS.